Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Cancer Research|June 15, 1995
Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferationH Miettinen, J Kononen, H Haapasalo, et al.
Lancet (London, England)|December 10, 1994
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancerU H Stenman, M Hakama, P Knekt, et al.
Life Sciences|January 1, 1993
Topology of two DBI receptors in human lymphocytesA Berkovich, C Ferrarese, G Cavaletti, et al.
Stroke|January 8, 2000
Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in strokeJ S Leinonen, J P Ahonen, K Lönnrot, et al.
European Journal of Clinical Investigation|July 17, 2001
Serum homocysteine does not associate with uncomplicated coronary heart diseaseS T Nikkari, A Kalela, T A Koivu, et al.
Journal for Nurses in Staff Development : JNSD : Official Journal of the National Nursing Staff Development Organization|April 4, 2000
Transcultural Patient Care Committee: actualizing concepts and developing skillsM A Severson, S J Leinonen, N N Matt-Hensrud, et al.
Cancer Research|January 1, 1991
A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancerU H Stenman, J Leinonen, H Alfthan, et al.
Clinical Chemistry|October 3, 1999
Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: increased immunoreactivity in patients with biliary tract cancerJ Hedström, C Haglund, E Kemppainen, et al.
The Journal of Urology|November 7, 2001
Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in FinlandM Hakama, U H Stenman, A Aromaa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 28, 1998
Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patientsJ S Leinonen, V Rantalaiho, T Solakivi, et al.
Pageof 17